Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$2.59 - $3.64 $68,168 - $95,804
26,320 Added 75.56%
61,152 $184,000
Q2 2023

Aug 14, 2023

BUY
$3.63 - $6.38 $126,440 - $222,228
34,832 New
34,832 $151,000
Q1 2022

May 16, 2022

SELL
$2.75 - $4.39 $29,301 - $46,775
-10,655 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$3.4 - $5.19 $36,227 - $55,299
10,655 New
10,655 $40,000
Q3 2021

Nov 15, 2021

SELL
$3.84 - $5.38 $74,476 - $104,345
-19,395 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$4.24 - $6.57 $38,287 - $59,327
9,030 Added 87.12%
19,395 $102,000
Q1 2021

May 17, 2021

SELL
$5.7 - $13.31 $52,479 - $122,545
-9,207 Reduced 47.04%
10,365 $60,000
Q4 2020

Feb 16, 2021

BUY
$3.76 - $8.8 $73,590 - $172,233
19,572 New
19,572 $127,000

Others Institutions Holding OCUP

About Ocuphire Pharma, Inc.


  • Ticker OCUP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,579,800
  • Market Cap $20.2M
  • Description
  • Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Its lead product candidate is Nyxol eye drops, a once-daily preservative-free eye drop formulation of phentolamine mesylate, which is in Phase III clinical tr...
More about OCUP
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.